Heshengtang Pharmaceutical

Gansu Heshengtang Pharmaceutical is a modernized Traditional Chinese Medicine (TCM) company headquartered in Lanzhou, China. The company specializes in the research, development, and industrial production of Chinese patent medicines, leveraging the unique herbal resources of the Gansu province, such as Angelica sinensis (Danggui). Its primary product portfolio focuses on pediatric health, gynecological treatments, and respiratory conditions, with several proprietary formulations reaching significant market share in China. Heshengtang operates high-standard GMP-certified manufacturing lines and focuses on the 'secondary development' of traditional formulas using modern pharmaceutical technology. The company is publicly traded on the National Equities Exchange and Quotations (NEEQ) in China.